Vascular Simulations Launches Replicator Pro System

September 21, 2018—Vascular Simulations announced the launch of the Replicator Pro vascular replication system at TCT 2018, the 30th annual Transcatheter Cardiovascular Therapeutics scientific symposium, which is sponsored by CRF and held September 21–25 in San Diego, California. The company is offering the Replicator Pro as an alternative to device-reliance animal testing for a more representative testing platform for device development, demonstration, and training for engineers, educators, and physicians.

According to the company, Replicator Pro recreates the realistic hemodynamic environment. The system's treated silicone vasculature provides the tactile feedback for interventional device track and navigation, allowing devices to behave in Replicator Pro the same way they would in human vessels.

The Replicator Pro model includes matched aortoiliac vasculature and a four-chamber silicone heart with a replaceable, physiologically functioning aortic valve. This three-dimensional printed anatomy works with the endovascular-responsive terrain and system control unit to give the system its advanced hemodynamics. Additionally, Replicator Pro mimics the clinical environment through angiographic compatibility, giving physicians the ability to track and map their procedures, stated Vascular Simulations.

Apostolos Tassiopoulo, MD, commented in the company's announcement, "By giving the user the ability to perform a simulated procedure that takes place in the same hemodynamic conditions as it would in real life, there is an added fidelity component to the simulated procedure and it therefore makes the educational experience as close to reality as possible." Dr. Tassiopoulos, who is Director of Vascular and Endovascular Surgery at Stony Brook Hospital in Stony Brook, New York, continued, "In animal reliance testing, you never have the specific anatomy you are trying to treat, so Replicator Pro offers a much more relevant anatomical and hemodynamic environment."